Anti-inflammatory effect of semisolid dosage forms containing capsaicin

A Boiko  Yu; I.A.  Kravchenko; Ayat  Mohammad; A.A.  Shandra

doi:10.52981/sjms.v11i4.1116

A Boiko Yu Odessa National Medical University, Department of Physiology, Odessa, Ukraine
I.A. Kravchenko Odessa National I.I. Mechnikov University, Department of Pharmaceutical Chemistry, Odessa, Ukraine
Ayat Mohammad Odessa National I.I. Mechnikov University, Department of Pharmaceutical Chemistry, Odessa, Ukraine
A.A. Shandra Odessa National Medical University, Department of Physiology, Odessa, Ukraine

DOI: https://doi.org/10.52981/sjms.v11i4.1116

Keywords: capsaicin, ibuprophen, Freund’s adjuvant, inflammation

Abstract

Background: Capsaicin is alkaloid found primarily in the fruit of the Capsicum genus. Capsaicin and its analogues have been used in topical creams and patches to treat chronic pain and inflammation.

Objectives: The paper deals with topical application of creams containing capsaicin to treat Freund’s adjuvant-induced inflammation.

Materials and Methods: Anti-inflammatory activity was studied on the model adjuvantinduced inflammation with Freund's complete adjuvant. The study covered morphological changes in the inflamed area, the total number of white blood cells was studied by microscopic method in Gorjaev's chamber. The biochemical parameters of blood - cholinesterase activity and total number of alpha-1-acid glycoprotein in blood plasma were determined by the commercial test kits for rapid analysis

Results: It was shown that the cream containing Capsicum annuum L. extract proved to be more efficient for treatment of adjuvant-induced inflammation than the commercial drug Dolgit Cream. Application of therapeutic cream with Capsicum annuum L. extract reduced activity of plasma acetylcholinesterase and total WBC count on the 15 day of treatment to initial values.

Conclusion: The cream containing Capsicum annuum L. extract significantly inhibited inflammatory swelling, reduced WBC count and activity of plasma acetylcholinesterase.

References

1. Reyes-Escogido M.L., Gonzalez-Mondragon E.G., Vazquez-Tzompantzi E. Chemical and Pharmacological Aspects of Capsaicin. Molecules 2011; 16: 1253-1270.
2. Mashkovsky M.D. Medicinal Drugs. Part One. Issue Twelve. Medicine: Moscow, 1998.736 p.
3. Stefanov O.V. Pre-Clinical Studies of Medicinal Drugs. Avicenna: Kyiv, 2001.528 p.
4. M.M. Dale, J.C. Formen. Textbook of Immunopharmacology. Medicine: Moscow, 1998. 332 p.
5. Kwicien S., Konturek P. C., Sliwowski A. et al. Interaction between cyclooxygenase inhibitors and capsaicin-sensitive afferent sensory nerves in pathogenesis of stress-induced gastric lesion. Role of oxidative stress. J. Physiol. Pharmacol 2012; 63(2): 143-151 .
6. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Strasbourg: Council of Europe 1986; 123: 51 p.
7. General Ethics Principles of Animal Experiments. Endocrinol 2003; 8 (1): 142-145 .
8. Gonz ́alez-Aguilar G., Robles-S ́anchez R. M., Mart ́Õnez- T ́ellez M. A., Olivas G. I., Alvarez-Parrilla E., De La Rosa L. A. Bioactive compounds in fruits: health benefits and effect of storage conditions. Stewart Postharvest Review 2008; 4 (3): 1–10 .
9. Hern ́andez-Ortega M., Ortiz-MorenoA., Hern ́andez-Navarro M.D. et al. Antioxidant, Antinociceptive, and Anti-Inflammatory Effects of Carotenoids Extracted from Dried Pepper (Capsicum annuum L.). J. Biomed. Biotechnol. 2012; 2012: 1-10 (Article ID 524019, doi:10.1155/2012/524019) .
10. Edwards J.C., Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nature Rev. Immunol. 2006; 6: 394-403 .
11. Edwards J.C., Cambridge G. Sustained improvement of rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 2001; 40: 205-211
12. Suponitska E.V., Aleksandrova E.N. Alexankin A.P. et al. Homeostasis of B-cell and line of anti-B-cell therapy by rheumatoid arthritis. Rheumatology Research and Practice 2013; 51 (4): 432-438 .
13. Lesko S.M., Mitchell A.A. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA 1995; 273: 929-933 .
14. Tracey K.J. The inflammatory reflex. Nature 2002; 420: 853–859
15. Pavlov V.A., Wang H., Czura C.J., Friedman S.G., Tracey K.J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 2003; 9: 125–134.